Latest News

Waste, cost and carbon are converging to reshape how cataract centres choose instruments.

Home OCT now gives us the next dimension: time.

In this Q&A, Vance Thompson, MD, clears up myths about dry eye and LASIK wearing off, and explains how better screening and technology are making the procedure more precise for younger patients.

Findings highlight the need for routine bilateral endothelial assessment in herpetic eye disease

The phase 2 Early Vitrectomy and Intravitreal Antibiotics for Post-Operative Exogenous Endophthalmitis study showed that performing early vitrectomy for acute endophthalmitis can offer better and faster visual outcomes than the current treatment of prescribing antibiotics first.

Susvimo works in conjunction with the company’s port delivery platform, Contivue, which was specifically engineered for use with Susvimo.

Why AI-driven functional imaging could change how clinicians assess and treat retinal disease

PRIMA, the first brain-computer interface approved for form vision restoration (reading letters, numbers, words) in patients with geographic atrophy (GA) secondary to age-related macular degeneration, is commercially available in Europe.

David E. I. Pyott, CBE, MD(Hon), MBA, MA, discusses expanding subspecialty training and internationally recognized credentials in underserved regions.

The long-term outcomes after primary scleral buckling procedures for rhegmatogenous retinal detachments showed high anatomic success, improved vision, and a good safety profile.

Antineoplastics were the most frequently implicated drug class in review

Real-world data support EndoArt as donor-independent option in high-risk patients

Biologic therapies linked to high remission rates over 2-year follow-up